Literature DB >> 26485499

Improvement of Dream Enactment Behavior Associated With Levetiracetam Treatment in Dementia With Lewy Bodies.

Felipe Batalini1, Alon Avidan, Brian D Moseley, John M Ringman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 26485499      PMCID： PMC4834282          DOI： 10.1097/WAD.0000000000000113

Source DB:  PubMed          Journal:  Alzheimer Dis Assoc Disord        ISSN： 0893-0341            Impact factor:   2.703


× No keyword cloud information.
  11 in total

1.  Effects of levetiracetam on nocturnal sleep and daytime vigilance in healthy volunteers.

Authors:  Alessandro Cicolin; Umberto Magliola; Alessandra Giordano; Anna Terreni; Caterina Bucca; Roberto Mutani
Journal:  Epilepsia       Date:  2006-01       Impact factor: 5.864

2.  Best practice guide for the treatment of REM sleep behavior disorder (RBD).

Authors:  R Nisha Aurora; Rochelle S Zak; Rama K Maganti; Sanford H Auerbach; Kenneth R Casey; Susmita Chowdhuri; Anoop Karippot; Kannan Ramar; David A Kristo; Timothy I Morgenthaler
Journal:  J Clin Sleep Med       Date:  2010-02-15       Impact factor: 4.062

3.  Validation of the Mayo Sleep Questionnaire to screen for REM sleep behavior disorder in a community-based sample.

Authors:  Bradley F Boeve; Jennifer R Molano; Tanis J Ferman; Siong-Chi Lin; Kevin Bieniek; Maja Tippmann-Peikert; Brendon Boot; Erik K St Louis; David S Knopman; Ronald C Petersen; Michael H Silber
Journal:  J Clin Sleep Med       Date:  2013-05-15       Impact factor: 4.062

Review 4.  Breakdown in REM sleep circuitry underlies REM sleep behavior disorder.

Authors:  John Peever; Pierre-Hervé Luppi; Jacques Montplaisir
Journal:  Trends Neurosci       Date:  2014-03-24       Impact factor: 13.837

5.  Carbamazepine in REM sleep behavior disorder.

Authors:  C R Bamford
Journal:  Sleep       Date:  1993-01       Impact factor: 5.849

6.  The effect of levetiracetam monotherapy on subjective sleep quality and objective sleep parameters in patients with epilepsy: compared with the effect of carbamazepine-CR monotherapy.

Authors:  Yong Won Cho; Do Hyung Kim; Gholam K Motamedi
Journal:  Seizure       Date:  2011-05       Impact factor: 3.184

7.  The effects of levetiracetam on objective and subjective sleep parameters in healthy volunteers and patients with partial epilepsy.

Authors:  Caroline Bell; Hilde Vanderlinden; Reinhard Hiersemenzel; Christian Otoul; David Nutt; Sue Wilson
Journal:  J Sleep Res       Date:  2002-09       Impact factor: 3.981

8.  Levetiracetam suppresses neuronal network dysfunction and reverses synaptic and cognitive deficits in an Alzheimer's disease model.

Authors:  Pascal E Sanchez; Lei Zhu; Laure Verret; Keith A Vossel; Anna G Orr; John R Cirrito; Nino Devidze; Kaitlyn Ho; Gui-Qiu Yu; Jorge J Palop; Lennart Mucke
Journal:  Proc Natl Acad Sci U S A       Date:  2012-08-06       Impact factor: 11.205

Review 9.  Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium.

Authors:  I G McKeith; D W Dickson; J Lowe; M Emre; J T O'Brien; H Feldman; J Cummings; J E Duda; C Lippa; E K Perry; D Aarsland; H Arai; C G Ballard; B Boeve; D J Burn; D Costa; T Del Ser; B Dubois; D Galasko; S Gauthier; C G Goetz; E Gomez-Tortosa; G Halliday; L A Hansen; J Hardy; T Iwatsubo; R N Kalaria; D Kaufer; R A Kenny; A Korczyn; K Kosaka; V M Y Lee; A Lees; I Litvan; E Londos; O L Lopez; S Minoshima; Y Mizuno; J A Molina; E B Mukaetova-Ladinska; F Pasquier; R H Perry; J B Schulz; J Q Trojanowski; M Yamada
Journal:  Neurology       Date:  2005-10-19       Impact factor: 9.910

10.  Neurodegenerative disorder risk in idiopathic REM sleep behavior disorder: study in 174 patients.

Authors:  Alex Iranzo; Ana Fernández-Arcos; Eduard Tolosa; Mónica Serradell; José Luis Molinuevo; Francesc Valldeoriola; Ellen Gelpi; Isabel Vilaseca; Raquel Sánchez-Valle; Albert Lladó; Carles Gaig; Joan Santamaría
Journal:  PLoS One       Date:  2014-02-26       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.